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Abstract
Background: Multidisciplinary pain management programs based on cognitive behavioral training (CBT) principles
have been shown moderately effective in improving daily functioning in patients with chronic low back pain
(CLBP). To optimize health-related outcomes as daily functioning, a clear understanding of the working mechanisms
of these programs is warranted. Being confident to achieve a desired outcome, i.e. self-efficacy, is suggested to be a
more potent determinant for beneficial treatment outcomes than restructuring the patient’s dysfunctional
behavioral cognitions (pain catastrophizing and fear of movement [FoM]), but the evidence is scarce. The objective
of this study was twofold: 1) to determine whether a two-week pain management program resulted in post-
treatment improvements in self-efficacy and decreased dysfunctional behavioral cognitions in patients with CLBP,
and 2) to examine the unique contribution of self-efficacy to improvement in post-treatment disability.
Methods: A secondary analysis of an historical cohort study was performed, including 524 patients (59% females).
Primary outcome: functional status (Oswestry Disability Index v2.1a). Secondary outcomes: catastrophizing (Pain
Catastrophizing Scale), FoM (Tampa Scale for Kinesiophobia), and self-efficacy (Pain Self-Efficacy Questionnaire).
Assessments: pre-, post-treatment, 1, and 12-months follow-up. Paired Student’s t-tests were applied and clinical
relevancy of improvements was described using minimal clinical important changes. Adjusted multivariate linear
regression analyses were performed to explore the unique contribution of self-efficacy.
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Results: The mean age of patients was 46 (SD = 9.5) years and they had longstanding CLBP (mean 12.5 [SD = 10.8]
years). Mean functional status, self-efficacy, and dysfunctional behavioral cognitions improved significantly at post-
treatment, with improvements maintained at 12months follow-up. Post-treatment relevant improvements in self-
efficacy and dysfunctional behavioral cognitions ranged from 62.4% (FoM) to 68.7% (self-efficacy). Post-treatment self-
efficacy improved the model explaining post-treatment functional disability (basic model R2 = 0.49, F(6,517) = 83.67, p <
0.001; final model R2 = 0.57, F(8,515) = 85.20, p < 0.001). This was further substantiated by the relative contribution
(standardized betas) of self-efficacy: 5.67 times more than catastrophizing and 9.75 times more than FoM.
Conclusions: Targeting self-efficacy contributes to fast improvement in functional status for selected and motivated
patients with persistent CLBP. In pain management programs and (online) self-management programs for CLBP,
targeting patients’ self-efficacy should have a prominent place.
Keywords: Low back pain, Cohort studies, Pain management, Disability, Behavior, Self efficacy, Catastrophization, Self-
management, Spine
Introduction
Worldwide low back pain (LBP) is a highly common
health condition, affecting all age groups, and getting
more prevalent with the increasing and ageing world
population [1, 2]. In a series of papers of The Lancet
LBP Series Working Group the authors called for action
to develop and promote multidisciplinary and patient-
centred care focusing on self-management and healthy
lifestyles as a means of restoring and maintaining daily
functioning and optimizing (social) participation [3].
Multidisciplinary bio-psychosocial programs, based on
cognitive behavioural training (CBT) principles targeting
dysfunctional behavioural cognitions (catastrophizing,
fear of movement), have shown to be effective in im-
proving daily functioning in CLBP-patients [4, 5]. Al-
though recommended in international guidelines [6–8],
the working mechanisms are not yet fully understood.
To gain insight in the working mechanisms we previ-
ously evaluated a two-week, highly intense, residential
combined physical and psychological (CPP) pain man-
agement program for patients with longstanding severe
CLBP. Post-treatment clinically relevant improvements
were shown in self-efficacy beliefs and disability, result-
ing to ‘normal’ healthy functioning that remained stable
after a minimum of five-year follow-up [9, 10]. Although
it is assumed that in patients with longstanding persist-
ent pain, dysfunctional behavioural cognitions are resist-
ant to change [11], the fast improvements implicate that
these dysfunctional behavioural cognitions can be chan-
ged. It is still unclear to what extent these changes are
responsible for improvements in functional outcomes.
That would provide evidence that these indicators are
important treatment targets, and part of the working
mechanisms.
Furthermore, the question whether (pain) self-efficacy,
i.e. confidence and belief in one’s ability to achieve a de-
sired outcome [12], uniquely contributes to improved
functional outcome in longstanding CLBP, is still
unresolved. Examining whether targeting self-efficacy
and to what extent changes in self-efficacy uniquely con-
tribute to improvement in functional outcome is import-
ant to understand the working mechanisms. In a
systematic review of Jackson et al. [13], including 15,616
chronic pain patients (83 studies), the relevance is shown
as it facilitates recovery in terms of lower levels of dis-
ability and pain. CLBP programs based on CBT princi-
ples are likely to improve self-efficacy, leading to
improved disability and pain [2, 14, 15]. As such, pain
self-efficacy could be a more important determinant
than fear of movement in explaining disability [16, 17].
The purpose of this longitudinal study with CLBP-
patients was twofold: 1) to determine whether a two-
week residential CPP pain management program re-
sulted in post-treatment improvements in self-efficacy
and decreased dysfunctional behavioural cognitions and
subsequently, 2) to examine the unique contribution of
self-efficacy to improvement in post-treatment disability.
We hypothesized that the CPP pain management pro-
gram is able to decrease both pain catastrophizing and
fear of movement, due to post-treatment improvements
in self-efficacy, and that these improvements are main-
tained after a year.
Methods
Study design
The current cohort study is a secondary analysis with
data obtained for a previously published cohort study
that follows the STROBE guidelines [18]. The hospital’s
review board approved the study protocol. Ethical ap-
proval for this study was not deemed required, as the
Dutch Act on Medical Research involving Human Sub-
jects does not apply to screening questionnaires that are
part of routine clinical practice. All patients were in-
formed about the study and gave informed consent. For
this study, fully anonymized data were used.
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Participants
The orthopaedic spine surgeons consecutively recruited
the study participants. Patients were referred to the two
week residential CBT-based CPP pain management pro-
gram if they met the following main inclusion criteria:
age between 18 and 65 years, low back pain for at least
six months, failed conservative primary care treatment
and no indication for surgical or other invasive pain
treatment confirmed by spinal surgeons at the ortho-
paedic outpatient department, able to speak and read
Dutch, expressed their willingness and motivation to be-
havioural change, and wished to be enrolled in the in-
tensive two-week residential treatment. The main
exclusion criteria were diagnosed psychiatric disorders
and involvement in litigation claims. Final enrolment
was based on an extensive screening by the multidiscip-
linary team consisting of a psychologist, a physiotherap-
ist, an occupational therapist, and a psychomotor
therapist. During the screening patients’ willingness to
participate and motivation for behavioral change are dis-
cussed and the exclusion criteria checked (e.g. to ascer-
tain whether patients’ mental and/or physical problems
would interfere with the program).
Procedure
Intervention
A detailed description of the bio-psychosocial CPP pain
management program has previously been reported [19].
This program is based on CBT and exposure principles
and is designed as a so-called ‘pressure cooker’ modelled
program (100-h principle). Briefly, the two-week pro-
gram is delivered in a hotel facility by a multidisciplinary
team of allied healthcare professionals in collaboration
with and under the supervision of the orthopaedic spine
surgeons. The team has been trained in CBT and expos-
ure techniques for chronic pain. The program comprises
an intake assessment day, the 10-day residential program
and two days for the post-treatment follow-up assess-
ment at one and 12months. The intervention involves
approximately 100 h of participant contact time deliv-
ered in a group-orientated residential setting, including
intake assessment and follow-up assessments. The main
aim of the intervention is to improve daily functioning.
This goal is achieved by increasing the participant’s cap-
ability for self-management (self-efficacy), addressing the
psychological impact of pain and dysfunctional behav-
ioural cognitions (catastrophizing and fear of move-
ment), and increasing physical condition; all directed
toward enhancing return to work. The program is de-
scribed in a manual and consists of a range of CBT and
exposure techniques and self-management principles,
such as patient education, cognitive restructuring, expos-
ure to fearful situations, relaxation techniques, pacing,
goal setting, and homework assignments. Physical
training is an integral part of the treatment and includes
daily exercises to improve muscle strength, range of
movement, and physical fitness.
Measurement and data collection
As part of routine outcome assessment procedures, par-
ticipants completed questionnaires at intake (pre-treat-
ment), post-treatment (at the end of the two-week
program), at one and at 12 months post-treatment. Fur-
thermore, at pre-treatment participants provided infor-
mation on medical history including previous surgery,
pain history, current pain intensity (Numeric Rating
Scale [NRS 0–100]) [19], pain medication use, and em-
ployment status. At each assessment participants com-
pleted questionnaires on functional status, pain severity,
pain self-efficacy, pain catastrophizing and fear of move-
ment. All instruments used had previously been vali-
dated in Dutch CLBP samples.
Primary outcome measure
Functional status
The Dutch version of the Oswestry Disability Index
(ODI v2.1a) [20, 21] was used to assess functional status.
The 10-item ODI measures the impact of LBP on daily
functioning in ten domains of daily life. The total ODI
score is computed by summing the item scores; ranging
from 0 to 100, with higher scores indicating greater dis-
ability. A relative change measure, minimal clinical im-
portant change (MCIC) of 10 points was used to
indicate relevant improvement [22, 23].
Secondary self-report outcome measures
Self-efficacy
The Pain Self-Efficacy Questionnaire (PSEQ) was used
to assess participants’ ability to self-manage his or her
back pain complaints. The Pain Self-Efficacy Question-
naire (PSEQ) is a 10-item inventory that measures pa-
tient’s belief about his/her ability to accomplish a range
of activities despite his/her pain [24]. Scores range from
0 to 60, with higher scores indicating stronger self-
efficacy beliefs. An MCIC of 5.5 points was used to indi-
cate relevant improvement [25].
Catastrophizing
The Dutch version of the Pain Catastrophizing Scale
(PCS) was used to assess pain-related catastrophizing
[26, 27] was used to indicate change in catastrophizing.
The 13 items can be divided into three subscales (rumin-
ation, magnification and helplessness) and are scored on
a 5-point ordinal scale. The total score ranges between 0
and 52 points, with higher scores indicating higher levels
of pain catastrophizing. An MCIC of 5.8 points was used
to indicate relevant improvement [28].
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Fear of movement
The Tampa Scale for Kinesiophobia (TSK) was used to
assess fear of movement/(re-)injury in individuals with
pain [29, 30]. The 17 items are scored on a 4-point or-
dinal scale. The total score ranges between 17 and 68
points, with higher scores indicating higher levels of fear
of movement. An MCIC of 4.5 points was used to indi-
cate relevant improvement [28].
Data analyses
Data were checked and found normally distributed using
the Shapiro-Wilk test. Descriptive patient characteristics at
pre-treatment were summarized. Categorical data were de-
scribed in counts and percentages, whereas continuous var-
iables were described as means and standard deviations
(SD). To indicate whether there are relevant differences be-
tween complete and incomplete cases that might hamper
the generalization of findings, the percentage of ‘partial
cases’ (i.e. participants who did not respond to question-
naires) was calculated, and the pre-treatment characteristics
of partial cases and complete cases were compared with
Pearson chi-square tests for categorical variables and inde-
pendent Student’s t tests for continuous variables.
Missing data
To account for missing data on primary and secondary out-
come measures (partial cases) and to avoid possible bias by
excluding the data of these participants, a multiple imput-
ation (MI) technique (n = 10 sets) was performed. To gen-
erate the values to impute an augmentation Markov chain
Monte Carlo replacement method was used under the as-
sumption that the data were ‘missing at random’.
First hypothesis: improvement in dysfunctional
behavioural cognitions and self-efficacy
A paired Students’ t-test was used to examine pre- and
post-treatment values and post-treatment and 1 year
follow-up assessment values. Percentages of patients
reaching MCIC at post-treatment were described and ef-
fect sizes (Cohens’ d) were calculated to indicate the mag-
nitude of changes during the two-week program. Cohen’s
d is defined as the difference between means of the pre-
treatment assessment and the post-treatment assessment,
divided by the pooled standard deviation (SD). An effect
size of 1 is approximately equivalent to a change of 1 SD
in the sample: an effect size (d) of 0.2 is considered small,
0.5 moderate, while 0.8 indicates a large effect [31]. Partial
R2 was computed using GLM repeated measures ANOVA
to estimate the relevance of the treatment effect.
Second hypothesis: unique contribution of self-efficacy to
post-treatment disability
Multivariate linear regression techniques were applied.
Linear models were built to examine the influence of
self-efficacy, pain catastrophizing, and fear of movement
on the post-treatment functional status. Before con-
structing the models, the models’ assumptions were
checked [32]: linear relationships (Levene’s test), no per-
fect multicollinearity (Pearson’s [r] < 0.80; Variance In-
flation Factors < 10, and the corresponding tolerance
levels > 0.2), homoscedasticity between secondary (inde-
pendent) outcome indicators and primary (dependent)
outcome indicators, and the balance between the num-
ber of predictive indicators and the number of outcome
events was considered, which is recommended not to be
lower than 10–15 events per factor (EPV) [33, 34].
Model development.
Post-treatment functional status was used as a con-
tinuous (dependent) outcome indicator. In one block,
the pre-treatment values on primary and both pre and
post-treatment values on secondary outcomes, to indi-
cate change, were entered into the model as independent
variables. To adjust for pre-treatment differences in ex-
perienced pain, the baseline pain intensity score was
added. To calculate the relative contribution of post-
treatment self-efficacy to other independent variables,
standardized beta coefficients (β) were used. The models’
performances were assessed by the percentage of vari-
ance explained (i.e. Nagelkerke’s R2).
Data analyses were performed using STATA (version
13.0 for Windows; StataCorp, College Station, Texas, USA).
The level for statistical significance was set at p < 0.05.
Results
Response
In total 727 CLBP-patients were referred to the program.
After the multidisciplinary intake 524 (72.1%) were in-
cluded and participated in the program. Of this sample
(n = 524), 67 participants (12.8%) had missing data at
least at one post-treatment assessment after the pre-
treatment assessment [19]. At pre-treatment assessment,
the characteristics and the pre-treatment values on
measurement instruments were not significantly differ-
ent from participants with complete data.
Pre-treatment characteristics (Table 1)
The mean age of the total study population was 45.4
(SD = 9.6) years and the majority was female (58%). On
average, the participants had longstanding CLBP com-
plaints (mean 12.5 [SD = 10.8] years). The majority of
the participants were at work (68%) at the pre-treatment
assessment and one–third had previously undergone
surgery for their LBP (32%).
Improvement in dysfunctional behavioural cognitions and
self-efficacy (Table 2)
Mean primary and secondary outcome scores improved
significantly between pre- and post-treatment assessments.
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In two third of the patients a relevant improvement in self-
efficacy was shown after two weeks (MCIC 68.7%). The
percentage patients reaching MCIC for dysfunctional be-
havioural cognitions ranged from 62.0% (catastrophizing)
to 62.4% (fear of movement). Large effect sizes were found
for self-efficacy (d = 1.06, R2 = 0.53) and the dysfunctional
behavioural cognitions (i.e. catastrophizing: d = 1.08, R2 =
0.52; fear of movement: d = 1.06, R2 = 0.50); a moderate ef-
fect size was found for functional disability (d = 0.59, R2 =
0.23). Between the post-treatment and the one-year follow-
up assessment, a slight statistically significant improvement
was observed for functional disability (t(1,523) = 12.37, p <
0.001), catastrophizing (t(1,523) = 23.73, p < 0.001) and fear of
movement (t(1,523) = 23.01, p < 0.001). Self-efficacy remained
stable (t(1,523) = 0.66, p = 0.51). Moreover, for all outcomes
no relevant 1-year follow-up time effect is seen (R2 ranging
from 0.001 to 0.21), indicating that the improvements seen
directly post-treatment were maintained in the first year
following the treatment.
Unique contribution of self-efficacy to post-treatment disability
After correction for the influence of pre-treatment
values for functional disability, pain intensity, catastro-
phizing and fear of movement, the proposed multivariate
linear basic model to predict post-treatment functional
status based on post-treatment dysfunctional behav-
ioural cognitions was found to be significant (R2 = 0.49,
F(6,517) = 83.67, p < 0.001; Table 3). Only pre-treatment
Table 1 Pre-treatment characteristics of the total study sample, complete, and partial cases







Age, mean (SD) in years 45.4 (± 9.6) 45.5 (± 9.6) 44.5 (± 10.3)
Gender, Female n (%), 303 (57.8) 270 (59.1) 33 (49.3)
Employment status, Yes n (%) 356 (67.9) 317 (69.4) 39 (58.2)
CLBP History
Duration of LBP, mean (SD) in years 12.5 (±10.8) 12.4 (±10.8) 13.4 (±10.7)
Pain medication, Yes n (%) 454 (86.6) 397 (86.9) 57 (85.1)
Previous surgery, Yes n (%) 169 (32.3) 142 (31.1) 27 (40.3)
Current pain intensity (NPRS), mean (SD) 60.7 (± 21.1) 32.5 (± 10.8) 31.2 (± 12.1)
Primary outcome
Functional status (ODI), mean (SD) 41.4 (± 14.1) 41.1 (± 14.1) 43.9 (± 15.8)
Secondary outcomes
Self-efficacy (PSEQ), mean (SD) 32.4 (± 10.8) 32.5 (± 10.8) 31.2 (± 12.1)
Dysfunctional behavioural cognitions
Catastrophizing (PCS), mean (SD) 22.9 (± 8.9) 22.9 (± 8.8) 24.0 (± 9.5)
Fear of movement (TSK), mean (SD) 39.6 (± 6.4) 39.6 (± 6.4) 40.7 (± 6.7)
ODI oswestry disability index; PSEQ pain self-efficacy questionnaire; PCS pain catastrophizing scale; TSK tampa scale for kinesiophobia; NPRS numeric pain
rating scale
Table 2 Mean (SD), paired t-test values, and Cohens’ d effect sizes (n = 524)
Pre-treatment Post-treatment 1 yr FU Pre versus Post Post versus 1 yr FU
t(1,523) R
2 d t(1,523) R
2
Primary outcome
Functional status 41.1 (14.1) 34.5 (14.5) 27.2 (16.4) 12.37 0.23 0.59 11.60 0.21
Secondary outcomes
Self-efficacy 32.4 (10.8) 43.5 (10.0) 43.1 (12.0) −24.21 0.53 1.06 0.66 0.001
Dysfunctional behavioral cognitions
Catastrophizing 22.9 (8.8) 14.3 (7.0) 12.3 (7.5) 23.73 0.52 1.08 6.68 0.08
Fear of movement 39.6 (6.4) 32.7 (6.9) 31.8 (7.3) 23.01 0.50 1.06 3.11 0.02
Values in bold are statistically significant (p < 0.05)
FU 1 yr 1-year follow up; Pre pre-treatment assessment; Post post-treatment assessment
t t-value paired t-test; d Cohens’ d effect size
R2 treatment effect
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pain intensity had no significant influence on the out-
come (B = 0.22 [SE = 0.02], t = 1.06, p = 0.291). Addition
of self-efficacy improved the basic model (final model:
R2 = 0.57, F(8,515) = 85.20, p < 0.001; Table 3), showing
that after correcting for the pre-treatment value, only
post-treatment self-efficacy significantly contributed
(B = -0.56 [SE = 0.06], t = − 9.26, p < 0.001) to improved
functional status, with no significant influence of post-
treatment dysfunctional behavioural cognitions (cata-
strophizing B = 0.14 [SE = 0.09], t = 1.67, p = 0.095; fear
of movement B = 0.08 [SE = 0.06], t = 1.05, p = 293). This
was further substantiated by the relative contribution of
post-treatment self-efficacy to post-treatment functional
status, expressed in standardized betas, which is 5.67
times more than post-treatment.
Discussion
To understand the complexity of LBP the well-
established cognitive-behavioural ‘fear avoidance model’
[29, 35] is used to explain the development of chronic
LBP (CLBP) from an acute episode, and the maintenance
of persistent pain leading to pain-related disability [2, 29,
36]. However, the working mechanisms of multidiscip-
linary bio-psychosocial pain management programs,
based on cognitive behavioural training (CBT) principles,
are still poorly understood. This study showed that tar-
geting self-efficacy during an intensive two-week bio-
psychosocial combined physical and psychological (CPP)
pain management program is an important driver to a
fast improvement of functional status in patients with
longstanding and persistent chronic low back pain
(CLBP). Participants in this program are able to learn
and apply pain self-management principles in a short
amount of time. They learn to cope with dysfunctional
behavioural cognitions (pain catastrophizing and fear of
movement) and, based upon a previously published
study, they are able to manage their back problems at
least five years [10].
Improvement in dysfunctional behavioural cognitions and
self-efficacy
In this study the improvements in catastrophizing, fear
of movement, and self-efficacy observed at post-
treatment, were maintained at one-year follow-up, and
appeared larger compared to those reported in previous
studies [37, 38]. However, the findings in these studies
are based on less intensive programs compared to the
highly intense program under study. Intense programs
are assumed to reduce pain severity and to improve
functionality in patients with CLBP more effectively than
those that are less intensive. Although evidence to sup-
port this remains controversial [39, 40], it is tempting to
suggest that the large effect sizes and treatment gains re-
ported during those two weeks were the result of the in-
tense program. Other non-specific factors (moderators),
such as such a highly structured and standardized pro-
gram, clear treatment rationale and treatment goals
combined with a trained and highly skilled staff could
also have attributed to this effect [38, 41–43]. Further re-
search is needed to determine whether the treatment
Table 3 Predictive indicators of post-treatment functional status, adjusted for baseline functional status and pain intensity
Basic model Final model
B SE B B SE B β 95% CI
Post-treatment
Catastrophizing 0.49 0.08 0.14 0.09 0.07 [− 0.25, 0.31]
Fear of movement 0.24 0.08 0.08 0.08 0.04 [−0.07,0.24]
Self-efficacy −0.56 0.06 −0.39 [−0.68, − 0.44]
Pre-treatment
Catastrophizing −0.20 0.06 −0.13 0.06 −0.08 [−0.25, − 0.01]
Fear of movement − 0.30 0.09 − 0.26 0.08 −1.12 [− 0.42,-0.11]
Self-efficacy 0.05 0.05 0.03 [−0.05, 0.16]
Functional status 0.63 0.04 0.51 0.04 0.50 [0.43, 0.58]
Pain intensity 0.02 0.02 0.02 0.02 0.03 [−0.02, 0.06]




Multivariate linear regression models
Values in bold are statistically significant (p < 0.05)
B unstandardized beta coefficient; β standardized beta coefficient
SE standard error; CI confidence interval
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effect could be attributed to the ‘pressure cooker’ con-
cept or to any of the other moderators.
Key finding: unique contribution of self-efficacy to post-
treatment disability
Although the relevance of targeting self-efficacy is shown
in heterogeneous chronic pain samples [13], and the me-
diating role in CLBP is acknowledged in cross-sectional
studies [16, 17, 44] evidence still lacks showing its con-
tribution and role in the treatment of CLBP. The key
finding of the current study is that self-efficacy is a more
important and potent driver for fast improvements in
functional outcome than catastrophizing and fear of
movement. Adding changed (i.e. improved) self-efficacy
significantly contributes to post-treatment functional
outcome and also improved the basic model (Table 3,
R2 = 0.49 [basic model] to R2 = 0.57 [final model]). The
contribution of dysfunctional behavioural cognitions
(catastrophizing and fear of movement) was not signifi-
cant and considerably less than shown in the basic
model (Table 3). The unique contribution of improved
self-efficacy is also reflected in the standardized betas; al-
most 6 (catastrophizing) and 10 times (fear of move-
ment) higher.
As catastrophizing, fear of movement, and self-efficacy
significantly and relevantly improve during the two-week
intensive program, and are maintained at least for a year,
and acknowledging the fact that the constructs of these
indicators at least partially overlap [2], this suggests that
improvement of catastrophizing and fear of movement is
achieved by improved self-efficacy. Furthermore, these
rapid treatment gains can be achieved irrespective of the
initial level of self-efficacy believes, catastrophizing, fear
of movement, and experienced pain intensity. Notably,
post-hoc analyses showed that improvements in dys-
functional behavioral cognitions and self-efficacy beliefs
did not differ between patients with or without previous
surgery (Pearson Chi2 ranging from 0.03 to 1.14 [p >
0.05]). The study results indicate that targeting self-
efficacy during the program increases the patients’ be-
lieve that they are able to achieve improved functional
outcome. As such, they seem to quickly learn and inte-
grate self-management principles to control dysfunc-
tional behavioural cognitions and achieve improved
functional outcome. This supports the evidence that
self-efficacy is a more important determinant than fear
of movement in explaining disability [16, 17]. Besides a
systematic review in heterogeneous chronic pain samples
[13], to our knowledge this study is the first to show the
relevance of supporting the patient’s self-efficacy to fa-
cilitate recovery in terms of lower levels of disability in
large sample of selected patients with CLBP.
It is tempting to suggest that targeting self-efficacy fa-
cilitates recovery in patients with longstanding CLBP.
Despite the fact that the explained variance of the final
model was relatively high (R2 = 0.57, Table 3), other
(non-specific) moderating factors, as afore mentioned,
might also be of influence in post-treatment functional
outcome. In fact, during the two-week program a wide
range of CBT and exposure techniques are used, sustain-
ing the educational part of the program, which are
aimed at changing both self-efficacy and dysfunctional
behavioural cognitions in order to achieve improved
functional outcome. These findings seem to imply that
education at least to some extent, could be responsible
for the resulting strong effect in the primary functional
outcome that was found. Furthermore, a multidisciplin-
ary team of allied healthcare professionals (e.g. psycholo-
gist, physiotherapist, psychomotor therapist) usually
leads these programs. This suggests that supervision by
a medical specialist might not be instrumental for treat-
ment success, though this remains to be confirmed.
Strengths and limitations
An important strength of this study is the large sample
size (n = 524) and the low percentage of missing data.
Although 67 patients (13%) had incomplete data for at
least one assessment, no pre-treatment differences were
seen with those with complete data. By using imputation
techniques data of all patients could be used and as such
the conclusions based on the study findings are robust.
Some limitations of this study need to be mentioned.
First, due to the selection procedure for the program
generalization to common practice might be limited, as
only motivated patients with a high willingness to
change their behaviour were included. Patients vary on
the extent to which they are willing and ready to adopt a
self-management approach to their problem. Highly mo-
tivated patients, who believe that a pain management ap-
proach would help or who have decided to adopt a self-
management approach, are assumed ready to change
their pain-related behaviour. As such, motivation or will-
ingness to change might be of importance for treatment
dosage [42] and as selection criterion to match treat-
ments [41]. Second, the fear avoidance model suggests a
sequential progression for dysfunctional behavioural
cognitions. Although our study confirmed that changes
in dysfunctional behavioural cognitions occurred during
the two-week program, it can neither clarify the exact
moment during the program at which these changes oc-
curred, nor it was the focus of the current study. It is
also necessary to consider that the sequential parameters
of relations among catastrophizing, fear of movement
and disability may differ for the development of CLBP in
contrast to recovery of disability as a result of an inter-
vention [45].
In conclusion, in the treatment of selected and moti-
vated patients with longstanding persistent CLBP,
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targeting self-efficacy has a unique contribution to a fast
improvement of functional status. In treatments for
CLBP as CPP pain management programs and (online)
self-management programs targeting patients’ self-
efficacy should have a prominent place.
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